TABLE 2.
Confirmation of the designed universal EV cloning method efficiency in generating infectious clones
| Virus name | Length (nucleotides) | EV species | Colonies picked/total observed colonies | Positive colonies confirmed by colony PCR/total picked coloniesa (%)b | NGS analysisc |
Rescue confirmation (DNA/RNA) | |
|---|---|---|---|---|---|---|---|
| No. of determined reads | No. of determined reads mapping against the wild type (%) | ||||||
| EV-A71 | 7,400 | A | 10/41 | 8/10 (80) | 135,842 | 135,842 (100) | +/+ |
| CV-B5 | 7,402 | B | 10/45 | 8/10 (60) | 186,241 | 186,241 (100) | +/+ |
| ECHO6 | 7,418 | B | 10/38 | 6/10 (70) | 125,654 | 125,654 (100) | +/+ |
| ECHO30 | 7,428 | B | 10/36 | 7/10 (70) | 92,165 | 92,165 (100) | +/+ |
| CV-A24 | 7,458 | C | 10/64 | 5/10 (50) | 112,267 | 112,267 (100) | +/+ |
| EV-D68 | 7,333 | D | 10/45 | 8/10 (80) | 86,253 | 86,253 (100) | +/+ |
From the picked positive colonies, one sample of each EV serotype was subjected to further analysis using deep sequencing and rescue confirmation.
Cloning efficiency was calculated based on the method described by Beaty et al. (26).
Deep sequencing was performed using Illumina’s Nextera XT DNA library preparation kit. Determined reads were demultiplexed, quality trimmed, and filtered using CLC Genomics Workbench 7.0 at a minimum variant read frequency of 2%.